Evaluating Mindfulness and Psychoeducative Programs to Improve Quality of Life in Adults with Drug-Resistant Epilepsy

What this Trial Is About

Researchers are evaluating the impact of mindfulness on quality of life in patients with drug-resistant epilepsy, a condition often complicated by anxiety and depression. The study aims to assess if mindfulness can help patients better manage stress, self-acceptance, and emotional challenges related to their chronic condition. This non-drug approach is being compared to a psycho-educative program to find ways to improve well-being without medication side effects. The study has two phases. In the first phase, after a 2-month baseline period without intervention, participants are randomly assigned to either a mindfulness group or a psycho-educative group, each attending 12 weekly sessions over 3 months. Following this, both groups are monitored for 6 months. In the optional second phase, those originally in the psycho-educative group can join the mindfulness program and will be followed for an additional 6 months. Participants will attend regular assessment visits every 3 months and keep daily records of seizure frequency and emotional state. Researchers will evaluate quality of life using a specific questionnaire at 9 months and monitor changes in seizures, psychiatric symptoms, anxiety, stress, self-acceptance, and cognitive function. The study includes careful follow-up to understand how these interventions influence patients overall health and emotional well-being over time.

Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy.